AAAAAA

   
Results: 1-10 |
Results: 10
The role of middle molecules in uremia - Preliminary report of an international survey of nephrologists and scientists
Authors: Winchester, JF Brady, JA Ronco, C Yousha, E Smith, A Clemmer, J Muller, TE La Greca, G Levin, NW
Citation: Jf. Winchester et al., The role of middle molecules in uremia - Preliminary report of an international survey of nephrologists and scientists, CONTR NEPHR, 133, 2001, pp. 23-27
History of sorbents in uremia
Authors: Winchester, JF Ronco, C Brady, JA Clemmer, J Muller, TE Davankov, V Tsyurupa, M Pavlova, L Pavlov, M Levin, NW
Citation: Jf. Winchester et al., History of sorbents in uremia, CONTR NEPHR, 133, 2001, pp. 131-139
First clinical experience with an adjunctive hemoperfusion device designedspecifically to remove beta(2)-microglobulin in hemodialysis
Authors: Ronco, C Brendolan, A Winchester, JF Golds, E Clemmer, J Polaschegg, HD Muller, TE Davankov, V Tsyurupa, M Pavlova, L Pavlov, M La Greca, G Levin, NW
Citation: C. Ronco et al., First clinical experience with an adjunctive hemoperfusion device designedspecifically to remove beta(2)-microglobulin in hemodialysis, CONTR NEPHR, 133, 2001, pp. 166-173
Rationale for combined hemoperfusion/hemodialysis in uremia
Authors: Winchester, JF Ronco, C Brady, JA Brendolan, A Davankov, V Tsyurupa, M Pavlova, L Pavlov, M Clemmer, J Polaschegg, HD Muller, TE La Greca, G Levin, NW
Citation: Jf. Winchester et al., Rationale for combined hemoperfusion/hemodialysis in uremia, CONTR NEPHR, 133, 2001, pp. 174-179
Sorbent augmented dialysis: Minor addition or major advance in therapy?
Authors: Winchester, JF Ronco, C Brady, JA Golds, E Clemmer, J Cowgill, LD Levin, NW
Citation: Jf. Winchester et al., Sorbent augmented dialysis: Minor addition or major advance in therapy?, BLOOD PURIF, 19(2), 2001, pp. 255-259
First clinical experience with an adjunctive hemoperfusion device designedspecifically to remove beta(2)-microglobulin in hemodialysis
Authors: Ronco, C Brendolan, A Winchester, JF Golds, E Clemmer, J Polaschegg, HD Muller, TE La Greca, G Levin, NW
Citation: C. Ronco et al., First clinical experience with an adjunctive hemoperfusion device designedspecifically to remove beta(2)-microglobulin in hemodialysis, BLOOD PURIF, 19(2), 2001, pp. 260-263
L-carnitine and peritoneal dialysis
Authors: Winchester, JF
Citation: Jf. Winchester, L-carnitine and peritoneal dialysis, PERIT DIA I, 20, 2000, pp. S150-S153
Advances in renal replacement therapy: Into the new millennium
Authors: Winchester, JF Greenberg, A Keen, M Lindsay, RM Pereira, B
Citation: Jf. Winchester et al., Advances in renal replacement therapy: Into the new millennium, ADV RENAL R, 6(1), 1999, pp. 1-1
Telemedicine: Future promise for dialysis management
Authors: Winchester, JF Levine, B Collmann, J Schulman, KA Turner, JW Rathore, S Khanafer, N Alaoui, A Pania, N Al-Awaa, A Hoffman, L Hofilena, M Mun, SK
Citation: Jf. Winchester et al., Telemedicine: Future promise for dialysis management, SEMIN DIAL, 12, 1999, pp. S101-S103
Telecommunications and the dialysis patient
Authors: Winchester, JF
Citation: Jf. Winchester, Telecommunications and the dialysis patient, AM J KIDNEY, 34(1), 1999, pp. XXXVI-XXXVIII
Risultati: 1-10 |